ZURA — Zura Bio Balance Sheet
0.000.00%
- $93.67m
- -$69.62m
- 45
- 44
- 15
- 27
Annual balance sheet for Zura Bio, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | |
Standards: | — | USG | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | — | 0.729 | 0.014 | 99.8 | 176 |
Prepaid Expenses | |||||
Total Current Assets | — | 1.15 | 0.033 | 101 | 179 |
Net Property, Plant And Equipment | — | — | — | — | 0.091 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | — | 141 | 142 | 101 | 180 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | — | 0.272 | 1.83 | 20.3 | 19.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | — | 10.4 | 7.76 | 41.5 | 32.7 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | — | 130 | 134 | 59.3 | 147 |
Total Liabilities & Shareholders' Equity | — | 141 | 142 | 101 | 180 |
Total Common Shares Outstanding |